Connect with us

News

Scientists genetically engineer houseplant to remove carcinogens from air

Published

on

Scientists at the civil and environmental engineering department at the University of Washington have genetically modified a common houseplant to break down toxic molecules present in chlorinated water and gasoline. The plant, “pothos ivy”, was engineered to express a protein called 2E1 which enables the breakdown of benzene and chloroform into components the plant can use for its own needs. The targeted chemicals are found in small amounts inside typical households, building up over time, but the size of their molecules is too small to be caught by HEPA filters. Since exposure to these chemicals has been linked to cancer, this scientific accomplishment is good news for human health.

In their study published on December 19, 2018 in the journal Environmental Science & Technology, researchers Long Zhang, Ryan Routsong, and Stuart E. Strand described the process they used to modify the pothos ivy plant. The plant was chosen because it was robust and able to grow under many different conditions, and the protein used – P450 2E1, “2E1” for short – is naturally present in all mammals. In humans, 2E1 is in the liver and only turns on to break down alcohol, thus it’s not helpful for breaking down air pollutants. For this reason, the team’s work was focused on making its functionality available outside of the body – they call it a “green liver” concept.

The modified pothos ivy plant in the laboratory. | Credit: Mark Stone/University of Washington

A synthetic version of the 2E1 protein occurring in rabbits was introduced to the pothos ivy so that every cell expressed it. In a test tube trial performed after the genetic modification, chloroform concentration dropped 82 percent after three days, undetectable by six days, and the benzene concentration dropped 75 percent by day eight in vials containing the plants and respective gases. To achieve the benefits of the modified functionality in a household setting, the chemicals will need to be moved to where the plant is located. “If you had a plant growing in the corner of a room, it will have some effect in that room,” Stuart Strand, one of the scientist in the study, said. “But without air flow, it will take a long time for a molecule on the other end of the house to reach the plant.”

Benzene is a common industrial chemical used to make plastics, dyes, detergents, and pesticides, among other things, and is generally found in both rural and urban areas. Its links to cancer are very clear – the most common being leukemia – which has led to significant regulation. While the amount most are exposed to is very low, over time it can build up, especially in areas with heavy traffic, cigarette fumes, and low ventilation. Chloroform is a chemical used that can be released into the air when chlorine is used to clean drinking water, waste water, and swimming pools. Although no direct association between cancer and inhaled exposure to chloroform, the Environmental Protection Agency (EPA) considers it to be a probable human carcinogen due to studies linking high exposure via oral ingestion to cancer.

The process of engineering the plant to function as desired took the team over two years, a significant amount of time compared to the months-long processes of other similar modification projects. However, the time spent was considered to be worthwhile due to both the results achieved and the hardiness of the plant used. They are now working to add the breakdown of formaldehyde to the plant’s capabilities using a different protein. Formaldehyde is a substance present in most building products and tobacco smoke that is also linked to cancer, asthma, and allergies.

Advertisement

Accidental computer geek, fascinated by most history and the multiplanetary future on its way. Quite keen on the democratization of space. | It's pronounced day-sha, but I answer to almost any variation thereof.

Advertisement
Comments

Elon Musk

Trump’s invite for Elon just reshuffled Tesla’s big Signature Delivery Event

Tesla rescheduled its final Model S farewell to May 20 after Musk joined Trump in China.

Published

on

By

Tesla has rescheduled its Model S and Model X Signature Edition delivery event to Wednesday, May 20, 2026, after abruptly calling off the original May 12 celebration. The event will take place at Tesla’s factory at 45500 Fremont Boulevard in Fremont, California, the same location where the Model S first rolled off the line in 2012. Invitees received a follow-up email asking them to reconfirm attendance and download a new QR code ticket, with Tesla noting that all travel and accommodation expenses remain the buyer’s responsibility.

The reason behind the original cancellation came into focus the same day it was announced. President Trump invited Elon Musk, Apple’s Tim Cook, BlackRock’s Larry Fink, Boeing’s Kelly Ortberg, and executives from Goldman Sachs, Blackstone, Citigroup, and Meta to join his trip to China this week for a summit with President Xi Jinping. The agenda covers trade, artificial intelligence, export controls, Taiwan, and the Iran war, following weeks of escalating friction between Washington and Beijing over AI technology, sanctions, and rare earth exports. Trump wrote on Truth Social, “I am very much looking forward to my trip to China, an amazing Country, with a Leader, President Xi, respected by all.”

Tesla launches 200mph Model S “Gold” Signature in invite-only purchase

The vehicles at the center of all this are the last Model S and Model X units Tesla will ever build. Priced at $159,420 each, the 250 Model S and 100 Model X Signature Edition units come finished in Garnet Red with a one-year no-resale agreement, giving Tesla right of first refusal if the owner decides to sell. As Teslarati reported, the Model S defined Tesla’s early identity as a serious luxury automaker, and the Fremont factory line that built it is now being converted to manufacture Optimus humanoid robots.

Advertisement

Musk’s inclusion in the China delegation drew attention given his very public relationship with Trump, and the invitation signals the two have moved past and past grievances. Trump originally brought Musk on to lead the Department of Government Efficiency following his inauguration, and despite a sharp public dispute in mid-2025, the two have appeared together repeatedly in recent months. A seat on the China trip, the most diplomatically consequential visit of Trump’s current term, puts Musk back at the table on U.S. economic policy at a moment when Tesla’s China revenue remains one of the company’s most important financial pillars.

Continue Reading

News

Tesla launches its solution to rare but relevant Supercharger problem

Published

on

tesla supercharger
Credit: Tesla

Tesla has launched a new solution to a rare but relevant Supercharger problem with a new Virtual Waitlist, a remedy that will solve sequencing confusion when there is a line to charge at one of the company’s locations.

Teslarati reported on what we called the Virtual Queue last month. In rare occurrences, there were physical altercations at Superchargers when someone might have cut in line to charge. Tesla started to develop some sort of system that would resolve this issue, and now it is finally rolling it out.

Tesla launches solution to end Supercharger fights once and for all

It will start with a Pilot Program, and Tesla is calling it the ‘Waitlist.’

Advertisement

Announced on May 11 on the official TeslaCharging X account, the pilot program is currently active at sites in Los Gatos, Mountain View, and San Francisco in California, as well as San Jose, CA, and the Bronx, NY (East Gun Hill Road). Drivers are encouraged to share feedback directly through the Tesla app to refine the system before a potential broader rollout.

Advertisement

Tesla released the video above to showcase the feature, which automatically joins the waitlist when your vehicle has the Supercharger with the wait as the destination in the navigation. There is also a notification that lets you know your place in line.

In this specific example, the video shows that the wait is less than five minutes, and that there are two cars ahead of the one in the video:

Credit: Tesla

Having a wait at a Supercharger is relatively rare, but it does happen. It is even more frequent now that there are more EVs allowed to use the Supercharger Network. Those non-Tesla EVs can also join the queue, as Tesla added in its social media release of the pilot program that they can join the waitlist using the Tesla app.

The release of this program should help alleviate the rare risk of incidents at Superchargers. Tesla will expand this program as it sees fit, and it gathers valuable data and reviews from users.

Advertisement
Continue Reading

Investor's Corner

Tesla Optimus is already benefiting investors, top Wall Street firm says

Piper Sandler has updated its detailed valuation model for Tesla (NASDAQ: TSLA), concluding that at recent share prices around $400–$420, investors are essentially acquiring the company’s ambitious Optimus humanoid robot project at no extra cost.

Published

on

Credit: Tesla China

Tesla Optimus is already benefiting investors from a fiscal standpoint, at least that is what Alexander Potter at Piper Sandler, a top Wall Street firm covering the company, says.

Piper Sandler has updated its detailed valuation model for Tesla (NASDAQ: TSLA), concluding that at recent share prices around $400–$420, investors are essentially acquiring the company’s ambitious Optimus humanoid robot project at no extra cost.

Analyst Alexander Potter, in the firm’s latest “Definitive Guide to Investing in Tesla,” built a comprehensive framework covering 17 separate product lines.

This granular approach values Tesla’s core businesses—including electric vehicles, energy storage, Full Self-Driving (FSD) software, in-house insurance, Supercharging network, and a standalone robotaxi operation—at approximately $400 per share, without assigning any value to Optimus or related inference-as-a-service opportunities.

Advertisement

“At $400/share, we think investors can buy Optimus for ‘free,’” Potter stated in the note. Piper Sandler maintained its Overweight rating on Tesla shares and a $500 price target, which implicitly attributes roughly $100 per share to the robot-related businesses— a figure the analyst views as potentially conservative.

The updated model incorporates elements often overlooked by other sell-side analysts, such as detailed forecasts for Tesla’s insurance operations, Supercharger revenue, and a distinct valuation for the robotaxi business separate from FSD software licensing. It also accounts for Tesla’s 2025 CEO compensation plan for the first time.

Potter acknowledged that his estimates for 2026 and 2027 fall below Wall Street consensus, citing factors like declining deliveries from certain discontinued models and reduced regulatory credit income.

However, he expressed limited concern, noting that traditional vehicle delivery metrics are expected to matter less over time as FSD subscriber growth and robotaxi deployment metrics gain prominence. On Optimus specifically, Potter suggested the humanoid robot program, combined with inference services, “arguably will be worth more than Tesla’s other businesses combined,” though the firm has not yet produced formal long-term forecasts for these segments.

Advertisement

Elon Musk reveals shocking Tesla Optimus patent detail

Tesla shares have traded near the $400 range in recent sessions, reflecting ongoing investor focus on the company’s autonomous driving progress and expansion into robotics and AI. The Optimus project remains in early development stages, with Tesla aiming to deploy the robots initially for internal factory tasks before broader commercial applications.

This Piper Sandler analysis highlights the growing emphasis among some investors and analysts on Tesla’s long-term technology platform potential beyond its current automotive and energy businesses.

As with any forward-looking valuation, outcomes will depend on execution timelines, technological breakthroughs, regulatory approvals for autonomous systems, and market adoption of humanoid robotics—areas that carry significant uncertainty and execution risk.

Advertisement

The note underscores a common theme in Tesla coverage: differing views on how to quantify emerging high-growth opportunities like robotics within the company’s overall enterprise value. Investors are advised to consider their own risk tolerance and conduct thorough due diligence regarding these speculative elements.

Continue Reading